Last reviewed · How we verify
Tangningtongluo tablets
At a glance
| Generic name | Tangningtongluo tablets |
|---|---|
| Sponsor | Guizhou Bailing Group Pharmaceutical Co Ltd |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy (PHASE2)
- Tangningtongluo Tablet for People With Prediabetes (PHASE2)
- A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |